Fundraising FoxBurst Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Gencovegencove.cominMar 2019 · $3M
Gencove provides direct-to-consumer genetic sequencing and polygenic risk scoring for health insights.
BiotechDigital HealthHealthtechNew York, US
Tomaz Berisa(Executive Officer, Director)inJoseph Pickrell(Executive Officer, Director)in
BoardSara Eshelman(Director)in
Co-investorsBread And Butter Ventures, LlcSpero VenturesVersion One VenturesAlexandriaBalaji SrinivasanRefactor Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.